2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide

C37H49N9O4 — CID 70322621

IUPAC2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide
SMILESC=C(CN[C@H](C)CC1(c2nn[nH]n2)c2ccc(C(=O)NCC(C)(C)O)cc2CCc2cc(C(=O)NCC(C)(C)O)ccc21)N1CCCC1C#N
InChIInChI=1S/C37H49N9O4/c1-23(39-20-24(2)46-15-7-8-29(46)19-38)18-37(34-42-44-45-43-34)30-13-11-27(32(47)40-21-35(3,4)49)16-25(30)9-10-26-17-28(12-14-31(26)37)33(48)41-22-36(5,6)50/h11-14,16-17,23,29,39,49-50H,2,7-10,15,18,20-22H2,1,3-6H3,(H,40,47)(H,41,48)(H,42,43,44,45)/t23-,29?/m1/s1
InChIKeyOIRYCGAYAXHAPE-WIZGVZBGSA-N
MW683.86 g/mol
LogP2.50
Rot. Bonds13

About 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide

2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide (PubChem CID 70322621) has the molecular formula C37H49N9O4 and a molecular weight of 683.86 g/mol. Its IUPAC name is 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide.

Molecular Properties

Compound Name2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide
PubChem CID70322621
Molecular FormulaC37H49N9O4
Molecular Weight683.86 g/mol
Exact Mass683.39
IUPAC Name2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide
SMILESC=C(CN[C@H](C)CC1(c2nn[nH]n2)c2ccc(C(=O)NCC(C)(C)O)cc2CCc2cc(C(=O)NCC(C)(C)O)ccc21)N1CCCC1C#N
InChIInChI=1S/C37H49N9O4/c1-23(39-20-24(2)46-15-7-8-29(46)19-38)18-37(34-42-44-45-43-34)30-13-11-27(32(47)40-21-35(3,4)49)16-25(30)9-10-26-17-28(12-14-31(26)37)33(48)41-22-36(5,6)50/h11-14,16-17,23,29,39,49-50H,2,7-10,15,18,20-22H2,1,3-6H3,(H,40,47)(H,41,48)(H,42,43,44,45)/t23-,29?/m1/s1
InChIKeyOIRYCGAYAXHAPE-WIZGVZBGSA-N
XLogP2.50
TPSA192.18 Ų
H-Bond Donors6
H-Bond Acceptors10
Rotatable Bonds13
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500683.86
LogP ≤ 52.50
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1010

Analyze 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide?
The IUPAC name of 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide (CID 70322621) is 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide.
What is the SMILES notation for 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide?
The canonical SMILES for 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide is C=C(CN[C@H](C)CC1(c2nn[nH]n2)c2ccc(C(=O)NCC(C)(C)O)cc2CCc2cc(C(=O)NCC(C)(C)O)ccc21)N1CCCC1C#N.
What is the InChIKey of 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide?
The InChIKey is OIRYCGAYAXHAPE-WIZGVZBGSA-N. The full InChI is InChI=1S/C37H49N9O4/c1-23(39-20-24(2)46-15-7-8-29(46)19-38)18-37(34-42-44-45-43-34)30-13-11-27(32(47)40-21-35(3,4)49)16-25(30)9-10-26-17-28(12-14-31(26)37)33(48)41-22-36(5,6)50/h11-14,16-17,23,29,39,49-50H,2,7-10,15,18,20-22H2,1,3-6H3,(H,40,47)(H,41,48)(H,42,43,44,45)/t23-,29?/m1/s1.
What are the key properties of 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide?
2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide has a molecular weight of 683.86 g/mol, XLogP of 2.50, 13 rotatable bonds, 6 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2R)-2-[2-(2-cyanopyrrolidin-1-yl)prop-2-enylamino]propyl]-6-N,13-N-bis(2-hydroxy-2-methylpropyl)-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide is sourced from PubChem (CID 70322621), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).